This paper deals with the Bayesian analysis of binary response regression using Markov chain Monte Carlo (MCMC) methods, more specifically the Metropolis sampler, for posterior simulation. The methodology is illustrated with real-world data from a bioassay experiment. Inference about quantities of typical interest in the dose-response setting such as the lethal dose is discussed as well. MCMC are routinely implemented through popular Bayesian software such as Win-/Open-BUGS. However, these remain black boxes which provide no insight in the estimation procedure. This paper exemplifies that developing and implementing an MCMC sampler may, in many practical situations, be relatively straightforward. The R code for the Metropolis sampler is also provided in an appendix to the paper.
Introduction
Dose-response (D-R) analyses represent an important pillar upon which toxicological analyses regarding drugs and putative environmental contaminants are built. They allow identifying a range of intakes (doses) encompassing an appropriate benefit-to-risk ratio. Acute toxicity of drugs and various chemical compounds is typically assessed through bioassay (biological assay) experiments. These consist of measuring the effects of a substance on living organisms under controlled conditions. Typically, batches of animals are administered various doses of a drug or a chemical (e.g., an insecticide), and the outcomes are usually recorded on a dichotomous scale: dead/alive, tumor/no tumor, etc. The same type of data may arise from observational studies on environmental contamination involving humans, animals or plants, by relating a health defect outcome to the level of exposure to an alleged contaminant, using appropriate proxies for exposure. Such an experiment or observational study typically yields data of the form ( , , ) i i i
x n y where i y denotes the number of individuals with positive outcome at dose i x out of a total of i n individuals.
Developing D-R models is central to determining "safe" and "hazardous" levels and dosages of drugs, potential pollutants and other substances to which humans, animals and plants are exposed. Conclusions of D-R analyses often serve as basis for public health regulations that limit exposure to hazardous substances (e.g., Mutshinda et al. 2008) .
Statistical analyses of D-R data have mainly revolved around the maximum-likelihood method (e.g. Metz et al. 1982 amongst many others). However, the steady increase in popularity of the Bayesian methodology (Clark 2005) has prompted substantial interest in implementing it in the D-R and exposure risk assessment settings (e.g., French et al. 2002; Teunis et al. 2002; Englehardt 2004; Englehardt & Swartout. 2004 , 2006 Mutshinda et al. 2008) . Bayesian inference offers attractive options whereby available information such as results from previous studies or experts' opinion in the form of a prior distribution can rationally be combined with information conveyed by empirical data and encoded in the likelihood function to boost the power of estimation. Owing to advances in sampling-based methods such as Markov chain Monte Carlo (MCMC) (Gilks et al. 1996) and the spread of related software in the vein of Win-/Open-BUGS (Spiegelhalter et al. 2003; Thomas et al. 2006) , the computational burden that has long hampered the broad adoption of the Bayesian approach, or limited its application to the computationally convenient conjugate analysis should overall no longer be an issue in itself.
This paper discusses the Bayesian analysis of binary response regression using MCMC, more specifically the (random walk) Metropolis sampler for posterior simulation. The methodology is illustrated in a practical example using real-world data from a bioassay experiment. In spite of the relatively large body of literature on Bayesian dose-response assessment, the subject is worthy of additional attention, in particular as numerical methods such as the MCMC implemented here are concerned. Indeed, the principles of these methods still need to be made broadly accessible to applied scientists. Notwithstanding the user-friendliness of available Bayesian software packages, these remain black boxes which provide no insight in the estimation process. This paper exemplifies that, in many practical cases, developing and implementing a MCMC sampler may be relatively straightforward once the underlying principles are well understood. In addition to a concise tutorial on generalized linear models under the umbrella of which falls binary response regression, this paper contributes to the literature by providing a handy explanation of the MCMC algorithm known as the Metropolis sampler, along with an illustration of its implementation in the increasingly popular R environment.
This paper is structured as follows. Section 2 presents the materials and methods. Section 3 deals with the analysis of the bioassay data, and section 4 is devoted to some conclusions.
Materials and methods

Description of data
We use real data from a bioassay experiment as presented Table 1 . The data were reproduced (with permission) from Gelman et al. (2003) , and are used here solely for illustrative purposes. The dichotomous outcomes are death/survival, and i y denotes the number of animals with positive outcome at dose i x (on the log-scale) out of i n . Gelman et al. (2003) analyzed the same dataset with a Bayesian approach by approximating the posterior distribution in two ways: (i) using crude simulations, and (ii) using the normal approximation to the posterior. Here we use MCMC to directly simulate samples from the joint posterior of the model parameters. By using the same dataset, we have the opportunity to compare the results across different methods, including the method of maximum likelihood which is briefly carried out in section 2.2.2.
Methods
The probability of positive outcome is related to the dose level through a logit (logistic regression) model. Logistic regression falls into the category of generalized linear models (GLMs) which underlie most of the statistical analyses in applied research. We revisit GLMs in subsection 2.2.1 without any attempt to presenting an exhaustive discussion. Readers interested in more details are referred to appropriate literature which includes McCullough & Nelder (1989) , Lindsey (1997) , and Dobson (2002) . In subsection 2.2.2 we fit the model to the bioassay data using the maximum likelihood method, and in subsection 2.2.3, we perform a MCMC-aided Bayesian analysis, simulating samples from the joint posterior of interest through a Metropolis sampler. where Y is a (column) vector of n iid Gaussian responses, X is a design matrix with n rows and ( 1) p + columns where p is the number of explanatory variables and the first column of X corresponds to the intercept. β is a (column) vector of the (p+1) regression parameters (including the intercept), and ε is a (column) vector of the n residuals which are assumed to be normally distributed with mean zero and variance 2 σ i.e. 
Gaussian as a linear transformation of Y which is Gaussian by assumption in the OLR setting. Nevertheless, even if the responses, i Y , are not normal, the OLS estimator β % , which coincides with the MLE β is still asymptotically normal as long as the variance is constant, by virtue of the renowned central limit theorem.
A GLM consists of the following three components. , the quantity log ( , ; ) /
commonly known as the score function, and in standard inference, it is known that
The function ( ) b θ is very important in GLMs as its first and second derivatives with respect to the natural parameter provide the mean and the variance functions, respectively. In the binomial case for instance, likelihood estimates have desirable large sample properties: as the sample size increases, they become unbiased, efficient, and normally distributed with the "true" value as mean and asymptotic covariance matrix given by the inverse of the Fisher information matrix (the negative of the Hessian matrix of log-likelihood evaluated at the maximum likelihood estimate). Moreover, MLEs are re-parameterization invariant (see below), and the likelihood function can be used to construct confidence intervals and to test hypotheses about models and parameters. More details on maximum likelihood estimation can be found in many statistical books such as Casella & Berger (2001) or Garthwaite et al. (2002) . Finding MLEs is an optimization problem which often requires iterative procedures.
In a dose-response setting, the outcomes of different trials are assumed to be (conditionally) independent given the level of dose. Hence, under controlled conditions, the dose-response relationship can be described by a logistic regression model. That is, |~( , )
where k is the number of dose levels, 1 β and 2 β are real-valued regression parameters. Consequently, the probability of positive outcome at dose level i x is given by With mortality data, a typical quantity of interest is the so-called lethal dose which represents the level of dose resulting in the death of a specific proportion of experimental subjects (typically animals in a preclinical experiment). The cure effective dose is similarly defined as the dose resulting in the cure of a specific proportion of experimental subjects.
Usually, the dose resulting in the death of half of the subjects, the so-called LD50 henceforth denoted by ϕ is reported. is the MLE of ϕ . In addition, φ is asymptotically Gaussian with a distribution centred at the true value, ϕ , and approximate covariance variance matrix W given by The posterior distribution is the legitimate tool for Bayesian inference whose conclusions are essentially made in terms of probabilistic statements about plausible parameter values or outcomes of future observations.
The derivation of the posterior distribution may be difficult to impossible, owing to integration involved in the normalizing constant ( ) p y . Historically, Bayesian analyses were confined to trivial situations where the integral can be ignored. These situations involve the use of the so-called conjugate priors where the likelihood and the prior combine in a nice fashion so that the posterior can be determined without integration because the posterior and the prior have the same form. For example, a binomial likelihood coupled with a beta prior yield a beta posterior, a Poisson likelihood coupled with a gamma prior yield a gamma posterior. The advent of the computationally intensive methods known as Markov Chain Monte Carlo (MCMC) methods has made Bayesian analysis feasible for a wide class of models. This simulation-based approach greatly simplifies Bayesian analysis. The two most popular MCMC algorithms are the Gibbs sampler (e.g. Gelfand & Smith 1990 ) and the Metropolis-Hastings (M-H) algorithm (Hastings, 1970; Chib & Greenberg 1995) For the purpose of our analysis, we first revisit M-H algorithm, which is an extension of the original Metropolis algorithm introduced by Metropolis et al. (1953) . Like any other MCMC method, the principle of the M-H sampler is to generate (dependent) samples β of the chain at step i. Each proposal is either accepted (meaning that the chain moves to the new state) or rejected (i.e. the chain remains in the same state), depending on the value of a test ratio. A description of the M-H algorithm is given below.
Pick
(1) β arbitrarily in the support of ( ) ( ) p y
Repeat 2 -3 until "convergence"
The proposal density q can be anything, but a symmetric proposal, meaning that , and 0 σ > is a tuning constant usually selected in such a way that roughly 20%-40% of the proposals are accepted. The pre-convergence part of the MCMC called "burn-in" is usually discarded, and the remaining part might be thinned to say every j th observation, for an integer 1 j > in order to reduce the correlation between consecutive draws. The thinning factor j is therefore the frequency with which successive parameter values are stored. After the burn-in and thinning of the MCMC, distributional summaries of the parameters of interest are produced from the stored samples.
Application to the bioassay data
We placed on the components of β independent and diffuse (with variance 1.0E+6) centered Gaussian priors. A random walk Metropolis was subsequently implemented, generating at step k proposals of the form
where z is a random draw from the bivariate standard Gaussian, and A is the Cholesky factor of the ML asymptotic covariance matrix C i.e., means
. Any symmetric and positive define (SPD) matrix (all covariance matrices are indeed SPD) has a Cholesky decomposition (see e.g. Gentle, 1998 for more details).
We initially ran 5000 iterations of the MCMC for a couple of times in order to select a suitable tuning factor σ . The value 2 σ = was retained as it yielded a roughly 32% acceptance probability. After the tuning constant was set, we ran 5000 burn-in iterations of the MCMC followed by a further 20000 iterations, and thinned the MCMC to every 10 th draw. A commented version of the R script implementing the sampler is provided in appendix B, where the variable nacc contains the number of accepted proposal and acc_prob contains the acceptance probability.
The MCMC reached the target distribution quite fast, and then proved to move freely over the parameter space. This good mixing is illustrated by the trace plots in Figure1 which display 1000 posterior samples for each component of the parameter β .
The sensitivity of the results to the prior inputs was assessed by varying the range of the priors by order of magnitudes, while starting the MCMC from dispersed points in the parameter space, but the results remained broadly robust to these changes.
All our results are reported on the scale of the log dose. The posterior mean, β was (1.35, 12.37) , which is relatively close to Gelman et al.'s approximate posterior (1.37, 11.93) 
Contour plots generally provide a better approach to displaying three-dimensional continuous data than the three-dimensional hidden-line plots. The un-normalized posterior was estimated at a 100 by 100 grid: Figure 2 (R code in appendix C). It can also be seen from this graph that the posterior mode is roughly equal to the ML estimate as expected under non-informative prior. However, the Bayesian approach allows for an effective handling of uncertainty through the posterior distribution. This is particularly important when it comes to predictions and risk assessment where a suitable accommodation of uncertainty is crucial.
As already pointed out,
, as a function of the parameters, is defined by 
Conclusions
In this paper we have discussed the Bayesian analysis of binary response regression using MCMC, more specifically the Metropolis sampler, for posterior simulation. We illustrated the methodology with real-world data from a bioassay experiment. The results were compared across different methods of posterior approximation and compared to their maximum likelihood counterparts. It is worth emphasizing that the bioassay dataset analyzed here was selected solely for illustration. There were only 5 replicates by level of dose, which resulted in low estimation precision as reflected by the large standard errors of the estimates.
In biological control, pest organisms may evolve over time with some characteristics that allow them to buffer the effect of say, pesticides or insecticides. Sequential replication over specific time-periods is necessary in order to track possible evolution of the dose-response relationship. This can be done by including random effects for different time periods. Combining link functions and exponential family variation with random effects leads to the cutting edge generalized linear mixed models (GLMMs) (e.g., Skrondal & Rabe-Hesketh 2004) . GLMMs can easily be fitted with a Bayesian approach using MCMC. 
-----------------------------------------------------------------
Appendix A: R script for model fitting with the ML method -----------------------------------------------------------------x<-c (-0.86, -0.3, -0.05, 0.73); n<-c(5, 5, 5, 5); y<-c(0, 1, 3, 5) myfit<-glm(cbind(y, n-y)~x, family=binomial) # Getting the covariance matrix of the parameter vector C<-summary(myfit)$cov.unscaled 
----------------------------------------------------------------
